Effect of bivalirudin on aortic valve intervention outcomes study: a two-centre registry study comparing bivalirudin and unfractionated heparin in balloon aortic valvuloplasty
Annapoorna Kini(Mount Sinai Medical Center), George Dangas(Mount Sinai Hospital), Shyam Poludasu(Icahn School of Medicine at Mount Sinai), Samantha Sartori(Icahn School of Medicine at Mount Sinai), Mauricio G. Cohen(Santa Ana College), Robert Pyo(Albert Einstein College of Medicine), Roxana Mehran(Mount Sinai Hospital), Samin K. Sharma(Mount Sinai Health System), Pedro Moreno(Mount Sinai Hospital), Brian O’Neill(Henry Ford Health System), Prakash Krishnan(Mount Sinai Hospital), Michael C. Kim(Icahn School of Medicine at Mount Sinai), Usman Baber(Icahn School of Medicine at Mount Sinai), Evan Jacobs(University of Miami), Jason C. Kovacic(Victor Chang Cardiac Research Institute), Georgios J. Vlachojannis(Maasstad Ziekenhuis), Vikas Singh(University of Miami), Jennifer Yu(UNSW Sydney)
Cited by 25
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
|Circulation|2011|3.3k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
|Journal of the American College of Cardiology|2011|2.2k